96 related articles for article (PubMed ID: 2166672)
1. Pharmacokinetics of cilazapril during repeated oral dosing in healthy young volunteers.
Williams PE; Brown AN; Rajaguru S; Francis RJ; Bell AJ; Dewland PM
Eur J Drug Metab Pharmacokinet; 1990; 15(1):63-7. PubMed ID: 2166672
[TBL] [Abstract][Full Text] [Related]
2. A pharmacokinetic study of cilazapril in elderly and young volunteers.
Williams PE; Brown AN; Rajaguru S; Walters GE; McEwen J; Durnin C
Br J Clin Pharmacol; 1989; 27 Suppl 2(Suppl 2):211S-215S. PubMed ID: 2527535
[TBL] [Abstract][Full Text] [Related]
3. The pharmacokinetics and bioavailability of cilazapril in normal man.
Williams PE; Brown AN; Rajaguru S; Francis RJ; Walters GE; McEwen J; Durnin C
Br J Clin Pharmacol; 1989; 27 Suppl 2(Suppl 2):181S-188S. PubMed ID: 2527531
[TBL] [Abstract][Full Text] [Related]
4. A pharmacokinetic study of cilazapril in patients with congestive heart failure.
Rosenthal E; Francis RJ; Brown AN; Rajaguru S; Williams PE; Steiner J; Curry PV
Br J Clin Pharmacol; 1989; 27 Suppl 2(Suppl 2):267S-273S. PubMed ID: 2548554
[TBL] [Abstract][Full Text] [Related]
5. The pharmacokinetics and angiotensin converting enzyme inhibition dynamics of cilazapril in essential hypertension.
Meredith PA; Elliott HL; Reid JL; Francis RJ
Br J Clin Pharmacol; 1989; 27 Suppl 2(Suppl 2):263S-266S. PubMed ID: 2548553
[TBL] [Abstract][Full Text] [Related]
6. The pharmacokinetics and dose proportionality of cilazapril.
Massarella J; DeFeo T; Lin A; Limjuco R; Brown A
Br J Clin Pharmacol; 1989; 27 Suppl 2(Suppl 2):199S-204S. PubMed ID: 2527533
[TBL] [Abstract][Full Text] [Related]
7. The influence of food on the pharmacokinetics and ACE inhibition of cilazapril.
Massarella JW; DeFeo TM; Brown AN; Lin A; Wills RJ
Br J Clin Pharmacol; 1989; 27 Suppl 2(Suppl 2):205S-209S. PubMed ID: 2527534
[TBL] [Abstract][Full Text] [Related]
8. Angiotensin-converting enzyme (ACE)-inhibition in cirrhosis. Pharmacokinetics and dynamics of the ACE-inhibitor cilazapril (Ro 31-2848).
Gross V; Treher E; Haag K; Neis W; Wiegand U; Schölmerich J
J Hepatol; 1993 Jan; 17(1):40-7. PubMed ID: 8445218
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics of the converting enzyme inhibitor cilazapril in normal volunteers and the relationship to enzyme inhibition: development of a mathematical model.
Francis RJ; Brown AN; Kler L; Fasanella d'Amore T; Nussberger J; Waeber B; Brunner HR
J Cardiovasc Pharmacol; 1987 Jan; 9(1):32-8. PubMed ID: 2434791
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics of cilazapril in patients with renal failure.
Fillastre JP; Moulin B; Godin M; Williams PE; Brown AN; Francis RJ; Pinta P; Manfredi R
Br J Clin Pharmacol; 1989; 27 Suppl 2(Suppl 2):275S-282S. PubMed ID: 2527539
[TBL] [Abstract][Full Text] [Related]
11. Initial and steady state pharmacokinetics of cilazapril in congestive cardiac failure.
Wiseman MN; Elstob JE; Francis RJ; Brown AN; Rajaguru S; Steiner J; Dymond DS
J Pharm Pharmacol; 1991 Jun; 43(6):406-10. PubMed ID: 1681053
[TBL] [Abstract][Full Text] [Related]
12. Correlation between plasma concentration of cilazapril and haemodynamic and hormonal effects in healthy man.
Burnier M; Mooser V; Nussberger J; Waeber B; Brunner HR
Br J Clin Pharmacol; 1989; 27 Suppl 2(Suppl 2):189S-197S. PubMed ID: 2527532
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics of intravenous cilazaprilat in normal volunteers.
Whitehead EM; Walters GE; Williams PE; Johnston GD
Br J Clin Pharmacol; 1989 Jun; 27(6):873-5. PubMed ID: 2757899
[TBL] [Abstract][Full Text] [Related]
14. A review of the preclinical cardiovascular pharmacology of cilazapril, a new angiotensin converting enzyme inhibitor.
Waterfall JF
Br J Clin Pharmacol; 1989; 27 Suppl 2(Suppl 2):139S-150S. PubMed ID: 2527528
[TBL] [Abstract][Full Text] [Related]
15. Repeated administration of the converting enzyme inhibitor cilazapril to normal volunteers.
Nussberger J; Fasanella d'Amore T; Porchet M; Waeber B; Brunner DB; Brunner HR; Kler L; Brown AN; Francis RJ
J Cardiovasc Pharmacol; 1987 Jan; 9(1):39-44. PubMed ID: 2434792
[TBL] [Abstract][Full Text] [Related]
16. Comparison of the pharmacokinetics and pharmacodynamics of perindopril, cilazapril and enalapril.
Louis WJ; Conway EL; Krum H; Workman B; Drummer OH; Lam W; Phillips P; Howes LG; Jackson B
Clin Exp Pharmacol Physiol Suppl; 1992; 19():55-60. PubMed ID: 1327596
[TBL] [Abstract][Full Text] [Related]
17. A comparison of the pharmacokinetics and pharmacodynamics of cilazapril between Chinese and Caucasian healthy, normotensive volunteers.
Anderson PJ; Critchley JA; Tomlinson B
Eur J Clin Pharmacol; 1996; 50(1-2):57-62. PubMed ID: 8739812
[TBL] [Abstract][Full Text] [Related]
18. Antihypertensive effects and pharmacokinetics of single and consecutive doses of cilazapril in hypertensive patients with normal and impaired renal function.
Shionoiri H; Gotoh E; Takagi N; Takeda K; Yabana M; Kaneko Y
J Cardiovasc Pharmacol; 1988 Feb; 11(2):242-9. PubMed ID: 2452321
[TBL] [Abstract][Full Text] [Related]
19. Clinical pharmacology of cilazapril.
Kleinbloesem CH; Van Brummelen P; Francis RJ; Wiegand UW
Am J Med; 1989 Dec; 87(6B):45S-49S. PubMed ID: 2532460
[TBL] [Abstract][Full Text] [Related]
20. Clinical pharmacology of cilazapril.
Kleinbloesem CH; van Brummelen P; Francis RJ; Wiegand UW
Drugs; 1991; 41 Suppl 1():3-10. PubMed ID: 1712269
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
